Natural history of branch retinal vein occlusion: an evidence-based systematic review, Ophthalmology, vol.117, issue.6, 2010. ,
Natural history of central retinal vein occlusion: an evidence-based systematic review, Ophthalmology, vol.117, issue.6, 2010. ,
Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion, Eye, vol.22, issue.1, pp.42-48, 2008. ,
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, The New England Journal of Medicine, vol.331, issue.22, pp.1480-1487, 1994. ,
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant, Investigative Ophthalmology and Visual Science, vol.52, issue.1, pp.80-86, 2011. ,
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis, Archives of Ophthalmology, vol.129, issue.5, pp.545-553, 2011. ,
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema, Ophthalmology, vol.121, issue.10, pp.1904-1914, 2014. ,
Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome, Investigative Ophthalmology and Visual Science, vol.54, issue.5, pp.3320-3324, 2013. ,
Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa, vol.251, pp.1501-1506, 2013. ,
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion, Ophthalmology, vol.117, issue.6, pp.1134-1137, 2010. ,
Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed, British Journal of Ophthalmology, vol.97, issue.8, pp.1040-1044, 2013. ,
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up-the SOLO study, Acta Ophthalmologica, vol.91, issue.5, pp.340-347, 2013. ,
Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion, Eye, vol.27, issue.7, pp.816-822, 2013. ,
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema, Archives of Ophthalmology, vol.125, issue.3, pp.309-317, 2007. ,
Proper method for calculating average visual acuity, Journal of Refractive Surgery, vol.13, issue.4, pp.388-391, 1997. ,
Visual acuities 'hand motion' and 'counting fingers' can be quantified with the freiburg visual acuity test, Investigative Ophthalmology & Visual Science, vol.47, issue.3, pp.1236-1240, 2006. ,
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion, European Journal of Ophthalmology, vol.24, issue.1, pp.1-9, 2014. ,
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results, Ophthalmology, vol.118, issue.12, pp.2453-2460, 2011. ,
Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion, Ophthalmologica, vol.229, issue.1, pp.21-25, 2013. ,
Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors, Current Drug Safety, vol.10, issue.2, pp.145-151, 2015. ,
Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease, Klinische Monatsblatter fur Augenheilkunde, vol.230, issue.4, pp.396-400, 2013. ,
Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function, Retina, vol.34, issue.2, pp.330-341, 2014. ,
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant, Ophthalmology, vol.119, issue.6, pp.1190-1198, 2012. ,
Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion, Eye, vol.27, issue.1, pp.65-71, 2013. ,
The etiology of steroid cataract, Journal of Ocular Pharmacology and Therapeutics, vol.23, issue.5, pp.403-420, 2007. ,
Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up, Journal of Ocular Pharmacology and Therapeutics, vol.29, issue.6, pp.560-565, 2013. ,
Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (shasta study), Retina, vol.34, issue.2, pp.342-351, 2014. ,